EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alveolar epithelial paxillin in postnatal lung alveolar development

Mikaela Scheer, Priscilla Kyi, Tadanori Mammoto, Akiko Mammoto iD

Biology Open · 2025

DOI: 10.1242/bio.061939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology Open, 2025. Verfasst von Mikaela Scheer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Hauptthemen laut MEDLINE: Paxillin, Pulmonary Alveoli, Alveolar Epithelial Cells, Organogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association-American Stroke Association, NHLBI NIH HHS, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Focal adhesion protein, paxillin plays an important role in embryonic development. We have reported that paxillin controls directional cell motility and angiogenesis. The role of paxillin in lung development remains unclear. Paxillin expression is higher in mouse pulmonary alveolar epithelial type 2 (AT2) cells at postnatal day (P)10 (alveolar stage) compared to P0 (saccular stage). The alveolar and vascular structures are disrupted, lung compliance is reduced, and the postnatal survival rate is lower in tamoxifen-induced PxniΔAT2 neonatal mice, in which the levels of paxillin in AT2 cells are knocked down. Surfactant protein expression and lamellar body structure are also inhibited in PxniΔAT2 neonatal mouse lungs. The expression of lipid transporter ABCA3 and its transcriptional regulator CEBPA that control surfactant homeostasis is inhibited in PxniΔAT2 neonatal mouse AT2 cells. These findings suggest that paxillin controls lung alveolar development through CEBPA-ABCA3 signaling in AT2 cells. Modulation of paxillin in AT2 cells may be novel interventions for neonatal lung developmental disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaxillinPulmonary AlveoliAlveolar Epithelial CellsOrganogenesisAnimalsMiceAnimals, NewbornSignal TransductionATP-Binding Cassette Transporters

Stichwörter der Autor:innen

ABCA3CEBPALung developmentPaxillin

Substanzen

PaxillinAbca3 protein, mouseATP-Binding Cassette Transporters

Autor:innen und Institutionen

  • Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

ORCID-Profile: Akiko Mammoto

Förderung

  • American Heart Association-American Stroke Association
  • NHLBI NIH HHS
  • American Heart Association
  • Medical College of Wisconsin
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Scheer, M., Kyi, P., Mammoto, T., & Mammoto, A. (2025). Alveolar epithelial paxillin in postnatal lung alveolar development. Biology Open. https://doi.org/10.1242/bio.061939

Vancouver

Scheer M, Kyi P, Mammoto T, Mammoto A. Alveolar epithelial paxillin in postnatal lung alveolar development. Biology Open. 2025. doi:10.1242/bio.061939

BibTeX
@article{Scheer2025,
  author = {Scheer, Mikaela and Kyi, Priscilla and Mammoto, Tadanori and Mammoto, Akiko},
  title = {Alveolar epithelial paxillin in postnatal lung alveolar development},
  journal = {Biology Open},
  year = {2025},
  doi = {10.1242/bio.061939}
}
Kostenlos starten →